Lexington Biosciences Inc. (LXGTF)

[Sabretooth0071]

Yes it will change but not very much, Share price will change the cap as will the amount of outstanding shares. But as the outstanding shares are virtually static for the time being its pretty much on par with my estimate.

When the trials are over and FDA approval occurs the cap will definitely increase as more shares are sold and the PPS goes up leading to a very big change for the better.